Literature DB >> 16213226

Cdk4 promotes adipogenesis through PPARgamma activation.

Anna Abella1, Pierre Dubus, Marcos Malumbres, Sushil G Rane, Hiroaki Kiyokawa, Audrey Sicard, Françoise Vignon, Dominique Langin, Mariano Barbacid, Lluis Fajas.   

Abstract

Cell cycle regulators such as E2F1 and retinoblastoma (RB) play crucial roles in the control of adipogenesis, mostly by controlling the transition between preadipocyte proliferation and adipocyte differentiation. The serine-threonine kinase cyclin-dependent kinase 4 (cdk4) works in a complex with D-type cyclins to phosphorylate RB, mediating the entry of cells into the cell cycle in response to external stimuli. Because cdk4 is an upstream regulator of the E2F-RB pathway, we tested whether cdk4 was a target for new factors that regulate adipogenesis. Here we find that cdk4 inhibition impairs adipocyte differentiation and function. Disruption of cdk4 or activating mutations in cdk4 in primary mouse embryonic fibroblasts results in reduced and increased adipogenic potential, respectively, of these cells. We show that the effects of cdk4 are not limited to the control of differentiation; cdk4 also participates in adipocyte function through activation of PPARgamma.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16213226     DOI: 10.1016/j.cmet.2005.09.003

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  58 in total

1.  Abrogation of de novo lipogenesis by stearoyl-CoA desaturase 1 inhibition interferes with oncogenic signaling and blocks prostate cancer progression in mice.

Authors:  Vanessa Fritz; Zohra Benfodda; Geneviève Rodier; Corinne Henriquet; François Iborra; Christophe Avancès; Yves Allory; Alexandre de la Taille; Stéphane Culine; Hubert Blancou; Jean Paul Cristol; Françoise Michel; Claude Sardet; Lluis Fajas
Journal:  Mol Cancer Ther       Date:  2010-06-08       Impact factor: 6.261

2.  CEBPD reverses RB/E2F1-mediated gene repression and participates in HMDB-induced apoptosis of cancer cells.

Authors:  Yen-Chun Pan; Chien-Feng Li; Chiung-Yuan Ko; Min-Hsiung Pan; Pei-Jung Chen; Joseph T Tseng; Wen-Chun Wu; Wen-Chang Chang; A-Mei Huang; Esta Sterneck; Ju-Ming Wang
Journal:  Clin Cancer Res       Date:  2010-10-22       Impact factor: 12.531

3.  Cell cycle regulators in the control of metabolism.

Authors:  Emilie Blanchet; Jean-Sébastien Annicotte; Lluis Fajas
Journal:  Cell Cycle       Date:  2009-12-17       Impact factor: 4.534

4.  Fyn regulates adipogenesis by promoting PIKE-A/STAT5a interaction.

Authors:  Margaret Chui Ling Tse; Xia Liu; Seran Yang; Keqiang Ye; Chi Bun Chan
Journal:  Mol Cell Biol       Date:  2013-02-25       Impact factor: 4.272

Review 5.  Two-way communication between the metabolic and cell cycle machineries: the molecular basis.

Authors:  Joanna Kaplon; Loes van Dam; Daniel Peeper
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

6.  Peroxisome proliferator-activated receptor gamma regulates E-cadherin expression and inhibits growth and invasion of prostate cancer.

Authors:  Jean-Sébastien Annicotte; Irena Iankova; Stéphanie Miard; Vanessa Fritz; David Sarruf; Anna Abella; Marie-Laurence Berthe; Danièle Noël; Arnaud Pillon; François Iborra; Pierre Dubus; Thierry Maudelonde; Stéphane Culine; Lluis Fajas
Journal:  Mol Cell Biol       Date:  2006-10       Impact factor: 4.272

Review 7.  Sirtuins-Mediated System-Level Regulation of Mammalian Tissues at the Interface between Metabolism and Cell Cycle: A Systematic Review.

Authors:  Parcival Maissan; Eva J Mooij; Matteo Barberis
Journal:  Biology (Basel)       Date:  2021-03-04

8.  p16(Ink4a)-induced senescence of pancreatic beta cells enhances insulin secretion.

Authors:  Aharon Helman; Agnes Klochendler; Narmen Azazmeh; Yael Gabai; Elad Horwitz; Shira Anzi; Avital Swisa; Reba Condiotti; Roy Z Granit; Yuval Nevo; Yaakov Fixler; Dorin Shreibman; Amit Zamir; Sharona Tornovsky-Babeay; Chunhua Dai; Benjamin Glaser; Alvin C Powers; A M James Shapiro; Mark A Magnuson; Yuval Dor; Ittai Ben-Porath
Journal:  Nat Med       Date:  2016-03-07       Impact factor: 53.440

9.  CXC ligand 5 is an adipose-tissue derived factor that links obesity to insulin resistance.

Authors:  Carine Chavey; Gwendal Lazennec; Sylviane Lagarrigue; Cyrielle Clapé; Irena Iankova; Jacques Teyssier; Jean-Sébastien Annicotte; Julien Schmidt; Chikage Mataki; Hiroyasu Yamamoto; Rosario Sanches; Anna Guma; Vladimir Stich; Michaela Vitkova; Bénédicte Jardin-Watelet; Eric Renard; Robert Strieter; Antoinette Tuthill; Gôkhan S Hotamisligil; Antonio Vidal-Puig; Antonio Zorzano; Dominique Langin; Lluis Fajas
Journal:  Cell Metab       Date:  2009-04       Impact factor: 27.287

10.  miR-143 interferes with ERK5 signaling, and abrogates prostate cancer progression in mice.

Authors:  Cyrielle Clapé; Vanessa Fritz; Corinne Henriquet; Florence Apparailly; Pedro Luis Fernandez; François Iborra; Christophe Avancès; Martin Villalba; Stéphane Culine; Lluis Fajas
Journal:  PLoS One       Date:  2009-10-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.